InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,131.60
(
-0.23%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.28
(
-0.22%
)
Bitcoin
60,934.91
(
0.20%
)
Post# of 252389
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 7
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 111486

Sunday, 12/26/2010 12:14:59 AM

Sunday, December 26, 2010 12:14:59 AM

Post# of 252389
>>I would not rule out a finding of non-inferiority based on those numbers.<<

I'm not ruling it out. I'm just saying it doesn't look likely - at least if the SPA primary endpoint involves ACR20. Incyte's best bet might be to move the primary endpoint to ACR50 - if the FDA goes along.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up